KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Travere Therapeutics (TVTX) Non-Current Receivables: 2013-2016

  • Travere Therapeutics' Non-Current Receivables was N/A to $46.2 million in Q2 2016 from the same period last year, while for Jun 2016 it was $46.2 million, marking a year-over-year change of. This contributed to the annual value of $45.6 million for FY2015, which is N/A change from last year.
  • Per Travere Therapeutics' latest filing, its Non-Current Receivables stood at $46.2 million for Q2 2016, which was up 0.69% from $45.9 million recorded in Q1 2016.
  • Travere Therapeutics' 5-year Non-Current Receivables high stood at $46.2 million for Q2 2016, and its period low was $137,547 during Q1 2013.
  • For the 2-year period, Travere Therapeutics' Non-Current Receivables averaged around $45.7 million, with its median value being $45.7 million (2015).